StockData
Kodiak Sciences Inc. logo

Kodiak Sciences Inc. (KOD) stock

KODNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$96.80−3.93 (-3.90%)

Close on Nov 17, 2026Market cap $6.08BP/E –Yield –

Kodiak Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Kodiak Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$158.51M. For fiscal 2025 it was -$136.01M. The highest annual figure on record is -$16.05M in fiscal 2016.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$136.01M–
FY2024Dec 31, 2024-$117.32M–
FY2023Dec 31, 2023-$154.18M–
FY2022Dec 31, 2022-$206.46M–
FY2021Dec 31, 2021-$182.27M–
FY2020Dec 31, 2020-$83.43M–
FY2019Dec 31, 2019-$39.15M–
FY2018Dec 31, 2018-$29.03M–
FY2017Dec 31, 2017-$17.66M–
FY2016Dec 31, 2016-$16.05M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$46.24M–
Q1 FY2026Mar 31, 2026-$40.01M–
Q4 FY2025Dec 31, 2025-$39.38M–
Q3 FY2025Sep 30, 2025-$32.88M–
Q2 FY2025Jun 30, 2025-$34.67M–
Q1 FY2025Mar 31, 2025-$29.08M–
Q4 FY2024Dec 31, 2024-$30.07M–
Q3 FY2024Sep 30, 2024-$21.16M–
Q2 FY2024Jun 30, 2024-$26.49M–
Q1 FY2024Mar 31, 2024-$39.60M–
Q4 FY2023Dec 31, 2023-$32.24M–
Q3 FY2023Sep 30, 2023-$32.76M–
Q2 FY2023Jun 30, 2023-$41.96M–
Q1 FY2023Mar 31, 2023-$47.22M–
Q4 FY2022Dec 31, 2022-$55.08M–
Q3 FY2022Sep 30, 2022-$53.09M–
Q2 FY2022Jun 30, 2022-$55.14M–
Q1 FY2022Mar 31, 2022-$43.16M–
Q4 FY2021Dec 31, 2021-$59.04M–
Q3 FY2021Sep 30, 2021-$51.95M–
Q2 FY2021Jun 30, 2021-$36.66M–
Q1 FY2021Mar 31, 2021-$34.63M–
Q4 FY2020Dec 31, 2020-$27.02M–
Q3 FY2020Sep 30, 2020-$24.57M–
Q2 FY2020Jun 30, 2020-$13.91M–
Q1 FY2020Mar 31, 2020-$17.93M–
Q4 FY2019Dec 31, 2019-$11.29M–
Q3 FY2019Sep 30, 2019-$7.70M–
Q2 FY2019Jun 30, 2019-$12.95M–
Q1 FY2019Mar 31, 2019-$7.21M–
Q4 FY2018Dec 31, 2018-$8.34M–
Q3 FY2018Sep 30, 2018-$4.98M–
Q2 FY2018Jun 30, 2018-$4.45M–
Q1 FY2018Mar 31, 2018-$11.26M–
Q4 FY2017Dec 31, 2017-$4.90M–

More Kodiak Sciences figures

See a number that looks wrong?